PL371180A1 - Pyrimidotriazines as phosphatase inhibitors - Google Patents

Pyrimidotriazines as phosphatase inhibitors

Info

Publication number
PL371180A1
PL371180A1 PL02371180A PL37118002A PL371180A1 PL 371180 A1 PL371180 A1 PL 371180A1 PL 02371180 A PL02371180 A PL 02371180A PL 37118002 A PL37118002 A PL 37118002A PL 371180 A1 PL371180 A1 PL 371180A1
Authority
PL
Poland
Prior art keywords
pyrimidotriazines
phosphatase inhibitors
pyrimido
triazine
useful
Prior art date
Application number
PL02371180A
Other languages
English (en)
Polish (pl)
Inventor
Kevin Richard Guertin
Lina Quattrocchio Setti
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL371180A1 publication Critical patent/PL371180A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
PL02371180A 2001-12-27 2002-12-27 Pyrimidotriazines as phosphatase inhibitors PL371180A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34393701P 2001-12-27 2001-12-27
US39911002P 2002-07-26 2002-07-26

Publications (1)

Publication Number Publication Date
PL371180A1 true PL371180A1 (en) 2005-06-13

Family

ID=26993696

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02371180A PL371180A1 (en) 2001-12-27 2002-12-27 Pyrimidotriazines as phosphatase inhibitors

Country Status (19)

Country Link
US (1) US6642381B2 (enExample)
EP (1) EP1467996B1 (enExample)
JP (1) JP4188839B2 (enExample)
KR (1) KR100601769B1 (enExample)
CN (1) CN100402530C (enExample)
AT (1) ATE311388T1 (enExample)
AU (1) AU2002367190B2 (enExample)
BR (1) BR0215395A (enExample)
CA (1) CA2471265C (enExample)
DE (1) DE60207759T2 (enExample)
ES (1) ES2252554T3 (enExample)
JO (1) JO2242B1 (enExample)
MX (1) MXPA04006266A (enExample)
PA (1) PA8562901A1 (enExample)
PE (1) PE20030896A1 (enExample)
PL (1) PL371180A1 (enExample)
TW (1) TW200306313A (enExample)
UY (1) UY27606A1 (enExample)
WO (1) WO2003055883A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1439834A1 (en) * 2001-10-30 2004-07-28 Applied Research Systems ARS Holding N.V. Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
PL377620A1 (pl) 2002-11-18 2006-02-06 F. Hoffmann-La Roche Ag Diazynopirymidyny
US20040186151A1 (en) * 2003-02-12 2004-09-23 Mjalli Adnan M.M. Substituted azole derivatives as therapeutic agents
AU2004210711B2 (en) * 2003-02-12 2010-07-08 Transtech Pharma, Inc. Substituted azole derivatives as therapeutic agents
WO2005080346A1 (en) * 2004-02-12 2005-09-01 Transtech Pharma, Inc. Substituted azole derivatives, compositions, and methods of use
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
EP1991544B1 (en) * 2006-01-30 2018-08-15 vTv Therapeutics LLC Substituted imidazole derivatives and their use as ptpase inhibitors
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
WO2010083645A1 (en) * 2009-01-21 2010-07-29 Shanghai Targetdrug Co., Ltd PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9486433B2 (en) 2012-10-12 2016-11-08 Mochida Pharmaceuticals Co. Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
KR20150127599A (ko) 2013-03-15 2015-11-17 모치다 세이야쿠 가부시키가이샤 비알코올성 지방간염을 치료하기 위한 조성물 및 방법
US10441560B2 (en) 2013-03-15 2019-10-15 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194410B1 (en) * 1998-03-11 2001-02-27 Hoffman-La Roche Inc. Pyrazolopyrimidine and pyrazolines and process for preparation thereof
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
GB0022079D0 (en) 2000-09-08 2000-10-25 Inst Of Molecul & Cell Biology Novel protein tyrosine phosphatase inhibitor

Also Published As

Publication number Publication date
ES2252554T3 (es) 2006-05-16
PA8562901A1 (es) 2003-07-28
DE60207759D1 (de) 2006-01-05
DE60207759T2 (de) 2006-08-03
EP1467996A1 (en) 2004-10-20
CA2471265A1 (en) 2003-07-10
JP4188839B2 (ja) 2008-12-03
TW200306313A (en) 2003-11-16
JO2242B1 (en) 2004-10-07
BR0215395A (pt) 2004-12-07
JP2005517677A (ja) 2005-06-16
KR20040068981A (ko) 2004-08-02
PE20030896A1 (es) 2003-11-05
ATE311388T1 (de) 2005-12-15
WO2003055883A1 (en) 2003-07-10
CN1610683A (zh) 2005-04-27
KR100601769B1 (ko) 2006-07-19
EP1467996B1 (en) 2005-11-30
US6642381B2 (en) 2003-11-04
AU2002367190B2 (en) 2006-10-05
UY27606A1 (es) 2003-06-30
US20030153756A1 (en) 2003-08-14
AU2002367190A1 (en) 2003-07-15
MXPA04006266A (es) 2004-09-27
CA2471265C (en) 2010-02-09
CN100402530C (zh) 2008-07-16

Similar Documents

Publication Publication Date Title
PA8562901A1 (es) Inhibidores de la fosfatasa
MY134136A (en) Novel compounds comprising jak3 kinase inhibitors
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
PL369530A1 (en) Chemical compounds
ATE227567T1 (de) Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
TW200510407A (en) Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors
TR200000782T2 (tr) Resorsinol türevleri.
NO20073801L (no) Atineoplastiske kombinasjoner
MXPA05011296A (es) Conjugados de fosfonato inhibidores de la cinasa.
IL151313A0 (en) Lipase containing pharmaceutical compositions
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MXPA05012026A (es) Compuestos de azaindol como inhibidores de cinasa.
PL345993A1 (en) Novel salt form of pantoprazole
SG129448A1 (en) Preparation of 1,3-diphenylprop-2-en-1-one derivatives
MY133390A (en) Azabicyclic 5ht1 receptor ligands
GB9918429D0 (en) Organic compounds
WO2002047604A3 (fr) Utilisation des composes de la classe des chalcones pour inhiber la vascularisation d'une masse tumorale
WO2004060878A3 (en) Inhibitors of phosphatases
GB0103045D0 (en) Organic Compounds
PL1628979T3 (pl) Związki diaminopirolochinazolinowe jako inhibitory białkowej fosfatazy tyrozynowej
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
PL1633754T3 (pl) Związki diaminopirolochinazolinowe jako inhibitory białkowych fosfataz tyrozynowych
AU2003264707A1 (en) Use of a chrysanthellum extract
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
MY119962A (en) Phosphoric acid salt of an aromatic diamin.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)